(Q47281509)

13 January 2018

review article

1 reference

title

Rationale for the management of coronary syndromes with low-molecular-weight heparins (English)

1 reference

13 January 2018

author name string

E Gurfinkel

1

1 reference

13 January 2018

J Fareed

2

1 reference

13 January 2018

E Antman

3

1 reference

13 January 2018

M Cohen

4

1 reference

13 January 2018

B Mautner

5

1 reference

13 January 2018

language of work or name

English

0 references

publication date

1 September 1998

1 reference

13 January 2018

American Journal of Cardiology

published in

1 reference

13 January 2018

volume

82

1 reference

13 January 2018

issue

5B

1 reference

13 January 2018

page(s)

15L-18L

1 reference

13 January 2018

The pathogenesis of atherosclerosis: a perspective for the 1990s

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Are we mortgaging the medical profession?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Fibrinopeptide A and platelet factor levels in unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Fibrinopeptide A: a marker of acute coronary thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Importance of thrombosis and thrombolysis in silent ischaemia: comparison of patients with acute myocardial infarction and unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

The portable programmable microprocessor-driven real-time 12-lead electrocardiographic monitor: a preliminary report of a new device for the noninvasive detection of successful reperfusion or silent coronary reocclusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Time significance of acute thrombotic reactant markers in patients with and without silent myocardial ischemia and overt unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Aspirin, heparin, or both to treat acute unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Reactivation of unstable angina after the discontinuation of heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Platelet and leukocyte activation after myocardial infarction. Influence of enalapril.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Low-molecular-weight heparin: is small beautiful?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Antithrombotic agents in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900107-6

10.1016/S0002-9149(98)00107-6

7 January 2021

Identifiers

DOI

1 reference

13 January 2018

1 reference

13 January 2018